🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emily Li

ORCID: 0000-0002-0921-1344
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.

172 citations

Tatiana M. Prowell, Jennifer Gao, Laura L. Fernandes, Emily Li, Xiling Jiang +29 more

14 citations

Myra H. Wyckoff, Satyan Lakshminrusimha, Matthew A. Rysavy, Ravi M. Patel, Dhuly Chowdhury +83 more

1 citations

Haresh Kirpalani, Susan R. Hintz, Kristi L. Watterberg, Victoria E. Watson, Jean Lowe +95 more

61 citations

Emily Li, Brandon Benefield, Stanley Swat, Vincenzo B. Polsinelli, James Carr +5 more

4 citations

Daniel Arango Sumano, Dhruv A Bhatt, Aidan B Cullen, Cyrus M Hajian, Winnie Huang +20 more

0 citations

Arvind Nishtala, Emily Li, William W. Schultz, Abigail S. Baldridge, Jacob Groenendyk +5 more